OHSU researchers explore link between gut, brain health for people with HIV
October 13, 2026
$5.8 million award from NIH could lead to new therapies to address harmful inflammation.
ONPRC Stories
OHSU awarded $7.5 million to advance gene therapy for kidney diseases
October 08, 2026
Nakai lab receives three NIH grants to develop potential curative treatments for inherited kidney diseases.
OHSU researcher awarded $4.2 million to advance stem cell therapy for age-related macular degeneration
August 20, 2026
The NIH award supports development of stem cells designed to avoid immune rejection, preserve vision.
Study: Triple-dose regimen may permanently clear HIV in infected newborns
August 10, 2026
OHSU-led discovery in animal model could advance quickly to clinical trials in people.
Study reveals path for universal vaccine against malaria
July 01, 2026
A T cell-based vaccine that targets the parasite as it infects the liver opens new possibilities for malaria, other parasite vaccines.
OHSU enters discussions to transition ONPRC to primate sanctuary
February 11, 2026
OHSU board of directors approved a resolution that gives OHSU president six months to negotiate an agreement with the NIH.
OHSU board of directors to hold special public meeting on ONPRC
February 04, 2026
Board to consider a resolution that authorizes the OHSU president to enter negotiations with NIH on transitioning ONPRC to primate sanctuary; board will take public testimony.
OHSU awarded $6.7 million to study effects of cannabis use during pregnancy in people with HIV
September 22, 2025
Study will explore impact of THC use on maternal, placental, fetal health in context of HIV infection.
NIH awards OHSU scientists, collaborators $8.4 million to develop a cure for HIV
August 28, 2025
Only a handful of people in history have been cured of the virus; three have agreed to kick off landmark research project led by OHSU.
